The FDA is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a New York Times report.
The U.S. Food and Drug Administration is aiming to grant full approval of the Pfizer-BioNTech coronavirus vaccine by Labor Day or sooner, according to a new report.
The FDA now has an unofficial target date of early September, the Times reported. Previous speculation for full approval had ranged from early fall to next January.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Amazon violated US labor laws in Alabama union vote, labor official rulesAn NLRB officer has recommended that workers at an Amazon warehouse in Bessemer, Alabama hold a new election because Amazon broke US labor laws.
Consulte Mais informação »
Pfizer, Moderna raised COVID-19 vaccine prices for EU: reportPfizer and Moderna hiked their COVID-19 vaccine prices in the EU after AstraZeneca lost popularity there, report says
Consulte Mais informação »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Consulte Mais informação »
Federal labor board official recommends new vote for Amazon union electionThe union that tried — and failed — to organize Amazon warehouse workers in Bessemer, Alabama may get a do-over.
Consulte Mais informação »
More jobs saying how much they pay amidst labor shortage: BloombergBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Consulte Mais informação »
Blizzard president departs as game maker faces labor lawsuitBrack came under intense scrutiny after a complaint was filed over his leadership style. He exits amid a cultural reckoning at Activision Blizzard.
Consulte Mais informação »